OpenInsiders01Web Canada
SEC INSIDER TRANSACTIONS

Ferguson Enterprises Inc. /DE/ (FERG) Insider Transactions

Explore official ownership filings, with every record linked to its source.

Reported data · not live

FERG · Ferguson Enterprises Inc. /DE/

How to read this data ↗
More transaction filters

OR within codes/roles; AND between categories. Roles apply to buyers and sellers. Owner predicates match the same owner. Missing values fail numeric/date filters. Value is quantity × reported price for non-derivative rows only; derivative values are unknown. Amendments stay separate; joint owners do not duplicate rows.

Reset filters

Active filters: days=6m

Stale snapshot · Covered: filings 2026-05-14 to 2026-10-27 · 34 filings · fetched 2026-10-27T16:25:06Z

Recent reported activity

0purchase rows on this page
5sale rows on this page
108matching filing rows

Purchases and sales count original non-derivative P and S rows. Awards, gifts, exercises, derivatives and amendments are shown separately and are not described as market purchases.

Transaction / filedReporting owner(s)Code / securityQuantityPrice as filedOwnershipSource
2026-10-12Filed 2026-10-14Thees William T. JrOfficer · Chief Operating Officer
Filing context

Reported filing row; may be amended. Do not sum filings blindly.

F1 The Common Stock was received in settlement of a Conditional Share Award that vested on October 12, 2026.

F2 The Common Stock was received in settlement of an October 12, 2023 grant under the Ferguson Enterprises Inc. Performance Ordinary Share Plan 2019, pursuant to certification of performance on September 14, 2026, by the Compensation Committee.

F3 The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan established by the reporting person on May 27, 2026.

References: F3

S Sale (market/private)Common Stock · Non-derivative3,510D220DirectForm 4 ↗0001984020-26-000003
2026-10-12Filed 2026-10-14Thees William T. JrOfficer · Chief Operating Officer
Filing context

Reported filing row; may be amended. Do not sum filings blindly.

F1 The Common Stock was received in settlement of a Conditional Share Award that vested on October 12, 2026.

F2 The Common Stock was received in settlement of an October 12, 2023 grant under the Ferguson Enterprises Inc. Performance Ordinary Share Plan 2019, pursuant to certification of performance on September 14, 2026, by the Compensation Committee.

F3 The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan established by the reporting person on May 27, 2026.

References:

F WithholdingCommon Stock · Non-derivative2,794D220.04DirectForm 4 ↗0001984020-26-000003
2026-10-12Filed 2026-10-14Thees William T. JrOfficer · Chief Operating Officer
Filing context

Reported filing row; may be amended. Do not sum filings blindly.

F1 The Common Stock was received in settlement of a Conditional Share Award that vested on October 12, 2026.

F2 The Common Stock was received in settlement of an October 12, 2023 grant under the Ferguson Enterprises Inc. Performance Ordinary Share Plan 2019, pursuant to certification of performance on September 14, 2026, by the Compensation Committee.

F3 The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan established by the reporting person on May 27, 2026.

References: F2

A Award / grantCommon Stock · Non-derivative4,206A0DirectForm 4 ↗0001984020-26-000003
2026-10-12Filed 2026-10-14Thees William T. JrOfficer · Chief Operating Officer
Filing context

Reported filing row; may be amended. Do not sum filings blindly.

F1 The Common Stock was received in settlement of a Conditional Share Award that vested on October 12, 2026.

F2 The Common Stock was received in settlement of an October 12, 2023 grant under the Ferguson Enterprises Inc. Performance Ordinary Share Plan 2019, pursuant to certification of performance on September 14, 2026, by the Compensation Committee.

F3 The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan established by the reporting person on May 27, 2026.

References: F1

M Exercise / conversionCommon Stock · Non-derivative2,098A0DirectForm 4 ↗0001984020-26-000003
2026-10-12Filed 2026-10-14Winckler RichardOfficer · Chief Accounting Officer
Filing context

Reported filing row; may be amended. Do not sum filings blindly.

F1 The Common Stock was received in settlement of a Conditional Share Award that vested on October 12, 2026.

F2 The Common Stock was received in settlement of an October 12, 2023 grant under the Ferguson Enterprises Inc. Performance Ordinary Share Plan 2019, pursuant to certification of performance on September 14, 2026, by the Compensation Committee.

References: F1

M Exercise / conversionConditional Share Award · Derivative476D0DirectForm 4 ↗0001984098-26-000002
2026-10-12Filed 2026-10-14Winckler RichardOfficer · Chief Accounting Officer
Filing context

Reported filing row; may be amended. Do not sum filings blindly.

F1 The Common Stock was received in settlement of a Conditional Share Award that vested on October 12, 2026.

F2 The Common Stock was received in settlement of an October 12, 2023 grant under the Ferguson Enterprises Inc. Performance Ordinary Share Plan 2019, pursuant to certification of performance on September 14, 2026, by the Compensation Committee.

References:

F WithholdingCommon Stock · Non-derivative645D220.04DirectForm 4 ↗0001984098-26-000002
2026-10-12Filed 2026-10-14Winckler RichardOfficer · Chief Accounting Officer
Filing context

Reported filing row; may be amended. Do not sum filings blindly.

F1 The Common Stock was received in settlement of a Conditional Share Award that vested on October 12, 2026.

F2 The Common Stock was received in settlement of an October 12, 2023 grant under the Ferguson Enterprises Inc. Performance Ordinary Share Plan 2019, pursuant to certification of performance on September 14, 2026, by the Compensation Committee.

References: F2

A Award / grantCommon Stock · Non-derivative953A0DirectForm 4 ↗0001984098-26-000002
2026-10-12Filed 2026-10-14Winckler RichardOfficer · Chief Accounting Officer
Filing context

Reported filing row; may be amended. Do not sum filings blindly.

F1 The Common Stock was received in settlement of a Conditional Share Award that vested on October 12, 2026.

F2 The Common Stock was received in settlement of an October 12, 2023 grant under the Ferguson Enterprises Inc. Performance Ordinary Share Plan 2019, pursuant to certification of performance on September 14, 2026, by the Compensation Committee.

References: F1

M Exercise / conversionCommon Stock · Non-derivative476A0DirectForm 4 ↗0001984098-26-000002
2026-10-12Filed 2026-10-14Schlicher JakeOfficer · Chief Strategy Officer
Filing context

Reported filing row; may be amended. Do not sum filings blindly.

F1 The Common Stock was received in settlement of a Conditional Share Award that vested on October 12, 2026.

F2 The Common Stock was received in settlement of an October 12, 2023 grant under the Ferguson Enterprises Inc. Performance Ordinary Share Plan 2019, pursuant to certification of performance on September 14, 2026, by the Compensation Committee.

F3 The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan established by the reporting person on May 13, 2026.

References: F1

M Exercise / conversionConditional Share Award · Derivative1,876D0DirectForm 4 ↗0001984100-26-000004
2026-10-12Filed 2026-10-14Schlicher JakeOfficer · Chief Strategy Officer
Filing context

Reported filing row; may be amended. Do not sum filings blindly.

F1 The Common Stock was received in settlement of a Conditional Share Award that vested on October 12, 2026.

F2 The Common Stock was received in settlement of an October 12, 2023 grant under the Ferguson Enterprises Inc. Performance Ordinary Share Plan 2019, pursuant to certification of performance on September 14, 2026, by the Compensation Committee.

F3 The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan established by the reporting person on May 13, 2026.

References: F3

S Sale (market/private)Common Stock · Non-derivative3,138D218.74DirectForm 4 ↗0001984100-26-000004
2026-10-12Filed 2026-10-14Schlicher JakeOfficer · Chief Strategy Officer
Filing context

Reported filing row; may be amended. Do not sum filings blindly.

F1 The Common Stock was received in settlement of a Conditional Share Award that vested on October 12, 2026.

F2 The Common Stock was received in settlement of an October 12, 2023 grant under the Ferguson Enterprises Inc. Performance Ordinary Share Plan 2019, pursuant to certification of performance on September 14, 2026, by the Compensation Committee.

F3 The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan established by the reporting person on May 13, 2026.

References:

F WithholdingCommon Stock · Non-derivative2,499D220.04DirectForm 4 ↗0001984100-26-000004
2026-10-12Filed 2026-10-14Schlicher JakeOfficer · Chief Strategy Officer
Filing context

Reported filing row; may be amended. Do not sum filings blindly.

F1 The Common Stock was received in settlement of a Conditional Share Award that vested on October 12, 2026.

F2 The Common Stock was received in settlement of an October 12, 2023 grant under the Ferguson Enterprises Inc. Performance Ordinary Share Plan 2019, pursuant to certification of performance on September 14, 2026, by the Compensation Committee.

F3 The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan established by the reporting person on May 13, 2026.

References: F2

A Award / grantCommon Stock · Non-derivative3,761A0DirectForm 4 ↗0001984100-26-000004
2026-10-12Filed 2026-10-14Schlicher JakeOfficer · Chief Strategy Officer
Filing context

Reported filing row; may be amended. Do not sum filings blindly.

F1 The Common Stock was received in settlement of a Conditional Share Award that vested on October 12, 2026.

F2 The Common Stock was received in settlement of an October 12, 2023 grant under the Ferguson Enterprises Inc. Performance Ordinary Share Plan 2019, pursuant to certification of performance on September 14, 2026, by the Compensation Committee.

F3 The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan established by the reporting person on May 13, 2026.

References: F1

M Exercise / conversionCommon Stock · Non-derivative1,876A0DirectForm 4 ↗0001984100-26-000004
2026-10-12Filed 2026-10-14Brundage WilliamDirector · Officer · Chief Financial Officer
Filing context

Reported filing row; may be amended. Do not sum filings blindly.

F1 The Common Stock was received in settlement of an October 12, 2023 grant under the Ferguson Enterprises Inc. Long Term Incentive Plan 2019 (Conditional Share Awards), pursuant to certification of performance on September 14, 2026, by the Compensation Committee.

F2 Includes 439 shares of Common Stock received in respect of dividend equivalents with respect to such Conditional Share Awards.

F3 Represents Common Stock received as dividend equivalents upon vesting of Restricted Stock Units.

F4 The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan established by the reporting person on May 20, 2026.

References: F4

S Sale (market/private)Common Stock · Non-derivative5,986D218.74DirectForm 4 ↗0001984142-26-000003
2026-10-12Filed 2026-10-14Brundage WilliamDirector · Officer · Chief Financial Officer
Filing context

Reported filing row; may be amended. Do not sum filings blindly.

F1 The Common Stock was received in settlement of an October 12, 2023 grant under the Ferguson Enterprises Inc. Long Term Incentive Plan 2019 (Conditional Share Awards), pursuant to certification of performance on September 14, 2026, by the Compensation Committee.

F2 Includes 439 shares of Common Stock received in respect of dividend equivalents with respect to such Conditional Share Awards.

F3 Represents Common Stock received as dividend equivalents upon vesting of Restricted Stock Units.

F4 The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan established by the reporting person on May 20, 2026.

References: F3

A Award / grantCommon Stock · Non-derivative172A0DirectForm 4 ↗0001984142-26-000003
2026-10-12Filed 2026-10-14Brundage WilliamDirector · Officer · Chief Financial Officer
Filing context

Reported filing row; may be amended. Do not sum filings blindly.

F1 The Common Stock was received in settlement of an October 12, 2023 grant under the Ferguson Enterprises Inc. Long Term Incentive Plan 2019 (Conditional Share Awards), pursuant to certification of performance on September 14, 2026, by the Compensation Committee.

F2 Includes 439 shares of Common Stock received in respect of dividend equivalents with respect to such Conditional Share Awards.

F3 Represents Common Stock received as dividend equivalents upon vesting of Restricted Stock Units.

F4 The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan established by the reporting person on May 20, 2026.

References:

F WithholdingCommon Stock · Non-derivative5,925D220.04DirectForm 4 ↗0001984142-26-000003
2026-10-12Filed 2026-10-14Brundage WilliamDirector · Officer · Chief Financial Officer
Filing context

Reported filing row; may be amended. Do not sum filings blindly.

F1 The Common Stock was received in settlement of an October 12, 2023 grant under the Ferguson Enterprises Inc. Long Term Incentive Plan 2019 (Conditional Share Awards), pursuant to certification of performance on September 14, 2026, by the Compensation Committee.

F2 Includes 439 shares of Common Stock received in respect of dividend equivalents with respect to such Conditional Share Awards.

F3 Represents Common Stock received as dividend equivalents upon vesting of Restricted Stock Units.

F4 The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan established by the reporting person on May 20, 2026.

References: F1, F2

A Award / grantCommon Stock · Non-derivative8,928A0DirectForm 4 ↗0001984142-26-000003
2026-10-12Filed 2026-10-14Graham Ian T.Officer · See Remarks
Filing context

Reported filing row; may be amended. Do not sum filings blindly.

F1 The Common Stock was received in settlement of a Conditional Share Award that vested on October 12, 2026.

F2 The Common Stock was received in settlement of an October 12, 2023 grant under the Ferguson Enterprises Inc. Performance Ordinary Share Plan 2019, pursuant to certification of performance on September 14, 2026, by the Compensation Committee.

F3 The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan established by the reporting person on May 27, 2026.

Chief Legal Officer & Corporate Secretary

References: F1

M Exercise / conversionConditional Share Award · Derivative2,050D0DirectForm 4 ↗0001984156-26-000002
2026-10-12Filed 2026-10-14Graham Ian T.Officer · See Remarks
Filing context

Reported filing row; may be amended. Do not sum filings blindly.

F1 The Common Stock was received in settlement of a Conditional Share Award that vested on October 12, 2026.

F2 The Common Stock was received in settlement of an October 12, 2023 grant under the Ferguson Enterprises Inc. Performance Ordinary Share Plan 2019, pursuant to certification of performance on September 14, 2026, by the Compensation Committee.

F3 The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan established by the reporting person on May 27, 2026.

Chief Legal Officer & Corporate Secretary

References: F3

S Sale (market/private)Common Stock · Non-derivative1,854D218.74DirectForm 4 ↗0001984156-26-000002
2026-10-12Filed 2026-10-14Graham Ian T.Officer · See Remarks
Filing context

Reported filing row; may be amended. Do not sum filings blindly.

F1 The Common Stock was received in settlement of a Conditional Share Award that vested on October 12, 2026.

F2 The Common Stock was received in settlement of an October 12, 2023 grant under the Ferguson Enterprises Inc. Performance Ordinary Share Plan 2019, pursuant to certification of performance on September 14, 2026, by the Compensation Committee.

F3 The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan established by the reporting person on May 27, 2026.

Chief Legal Officer & Corporate Secretary

References:

F WithholdingCommon Stock · Non-derivative2,451D220.04DirectForm 4 ↗0001984156-26-000002
2026-10-12Filed 2026-10-14Graham Ian T.Officer · See Remarks
Filing context

Reported filing row; may be amended. Do not sum filings blindly.

F1 The Common Stock was received in settlement of a Conditional Share Award that vested on October 12, 2026.

F2 The Common Stock was received in settlement of an October 12, 2023 grant under the Ferguson Enterprises Inc. Performance Ordinary Share Plan 2019, pursuant to certification of performance on September 14, 2026, by the Compensation Committee.

F3 The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan established by the reporting person on May 27, 2026.

Chief Legal Officer & Corporate Secretary

References: F2

A Award / grantCommon Stock · Non-derivative4,109A0DirectForm 4 ↗0001984156-26-000002
2026-10-12Filed 2026-10-14Graham Ian T.Officer · See Remarks
Filing context

Reported filing row; may be amended. Do not sum filings blindly.

F1 The Common Stock was received in settlement of a Conditional Share Award that vested on October 12, 2026.

F2 The Common Stock was received in settlement of an October 12, 2023 grant under the Ferguson Enterprises Inc. Performance Ordinary Share Plan 2019, pursuant to certification of performance on September 14, 2026, by the Compensation Committee.

F3 The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan established by the reporting person on May 27, 2026.

Chief Legal Officer & Corporate Secretary

References: F1

M Exercise / conversionCommon Stock · Non-derivative2,050A0DirectForm 4 ↗0001984156-26-000002
2026-10-12Filed 2026-10-14Murphy Kevin MichaelDirector · Officer · See Remarks
Filing context

Reported filing row; may be amended. Do not sum filings blindly.

F1 The Common Stock was received in settlement of an October 12, 2023 grant under the Ferguson Enterprises Inc. Long Term Incentive Plan 2019 (Conditional Share Awards), pursuant to certification of performance on September 14, 2026, by the Compensation Committee.

F2 Includes 886 shares of Common Stock received in respect of dividend equivalents with respect to such Conditional Share Awards.

F3 Represents Common Stock received as dividend equivalents upon vesting of Restricted Stock Units.

F4 The Common Stock was received in settlement of a December 7, 2023 grant under the Ferguson Enterprises Inc. 2023 Omnibus Equity Incentive Plan (Performance-based Restricted Stock Units (PSUs)), pursuant to certification of performance on September 14, 2026, by the Compensation Committee.

F5 Includes 153 shares of Common Stock received in respect of dividend equivalents with respect to such PSUs.

F6 The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan established by the reporting person on June 5, 2026.

F7 The reported price represents the volume-weighted average price (VWAP) of shares sold on the New York Stock Exchange (NYSE). Sale prices for the reported transaction reported ranged between $216.32 and $217.09. Full information regarding the number of shares of Common Stock sold at each separate price in the range will be provided to the SEC, the Issuer or its shareholders upon request.

President & Chief Executive Officer

References: F6, F7

S Sale (market/private)Common Stock · Non-derivative11,259D216.78DirectForm 4 ↗0001984614-26-000003
2026-10-12Filed 2026-10-14Murphy Kevin MichaelDirector · Officer · See Remarks
Filing context

Reported filing row; may be amended. Do not sum filings blindly.

F1 The Common Stock was received in settlement of an October 12, 2023 grant under the Ferguson Enterprises Inc. Long Term Incentive Plan 2019 (Conditional Share Awards), pursuant to certification of performance on September 14, 2026, by the Compensation Committee.

F2 Includes 886 shares of Common Stock received in respect of dividend equivalents with respect to such Conditional Share Awards.

F3 Represents Common Stock received as dividend equivalents upon vesting of Restricted Stock Units.

F4 The Common Stock was received in settlement of a December 7, 2023 grant under the Ferguson Enterprises Inc. 2023 Omnibus Equity Incentive Plan (Performance-based Restricted Stock Units (PSUs)), pursuant to certification of performance on September 14, 2026, by the Compensation Committee.

F5 Includes 153 shares of Common Stock received in respect of dividend equivalents with respect to such PSUs.

F6 The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan established by the reporting person on June 5, 2026.

F7 The reported price represents the volume-weighted average price (VWAP) of shares sold on the New York Stock Exchange (NYSE). Sale prices for the reported transaction reported ranged between $216.32 and $217.09. Full information regarding the number of shares of Common Stock sold at each separate price in the range will be provided to the SEC, the Issuer or its shareholders upon request.

President & Chief Executive Officer

References: F4, F5

A Award / grantCommon Stock · Non-derivative3,608A0DirectForm 4 ↗0001984614-26-000003
2026-10-12Filed 2026-10-14Murphy Kevin MichaelDirector · Officer · See Remarks
Filing context

Reported filing row; may be amended. Do not sum filings blindly.

F1 The Common Stock was received in settlement of an October 12, 2023 grant under the Ferguson Enterprises Inc. Long Term Incentive Plan 2019 (Conditional Share Awards), pursuant to certification of performance on September 14, 2026, by the Compensation Committee.

F2 Includes 886 shares of Common Stock received in respect of dividend equivalents with respect to such Conditional Share Awards.

F3 Represents Common Stock received as dividend equivalents upon vesting of Restricted Stock Units.

F4 The Common Stock was received in settlement of a December 7, 2023 grant under the Ferguson Enterprises Inc. 2023 Omnibus Equity Incentive Plan (Performance-based Restricted Stock Units (PSUs)), pursuant to certification of performance on September 14, 2026, by the Compensation Committee.

F5 Includes 153 shares of Common Stock received in respect of dividend equivalents with respect to such PSUs.

F6 The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan established by the reporting person on June 5, 2026.

F7 The reported price represents the volume-weighted average price (VWAP) of shares sold on the New York Stock Exchange (NYSE). Sale prices for the reported transaction reported ranged between $216.32 and $217.09. Full information regarding the number of shares of Common Stock sold at each separate price in the range will be provided to the SEC, the Issuer or its shareholders upon request.

President & Chief Executive Officer

References: F3

A Award / grantCommon Stock · Non-derivative418A0DirectForm 4 ↗0001984614-26-000003

Imported instruments only. Joint owners do not multiply transactions. Amendments are separate filing rows, not additional trades. No aggregate trade totals are implied.